Cargando…

Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes

Dengue virus (DENV) infection is a major emerging disease widely distributed throughout the tropical and subtropical regions of the world affecting several millions of people. Despite constants efforts, no specific treatment or effective vaccine is yet available. Here we show a novel design of a DNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poggianella, Monica, Slon Campos, José L., Chan, Kuan Rong, Tan, Hwee Cheng, Bestagno, Marco, Ooi, Eng Eong, Burrone, Oscar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517776/ https://www.ncbi.nlm.nih.gov/pubmed/26218926 http://dx.doi.org/10.1371/journal.pntd.0003947

Ejemplares similares

DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
por: Slon Campos, Jose L., et al.
Publicado: (2017)

Sequential immunization induces strong and broad immunity against all four dengue virus serotypes
por: Hou, Jue, et al.
Publicado: (2020)

Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells
por: Slon Campos, J. L., et al.
Publicado: (2017)

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
por: Hou, Jue, et al.
Publicado: (2019)

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
por: Budigi, Yadunanda, et al.
Publicado: (2018)

The re-emergence of dengue in China
por: Ooi, Eng Eong
Publicado: (2015)

Dengue virus compartmentalization during antibody-enhanced infection
por: Ong, Eugenia Z., et al.
Publicado: (2017)

Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
por: Bifani, Amanda Makha, et al.
Publicado: (2021)

Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
por: Chawla, Tanu, et al.
Publicado: (2013)

Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness
por: Finol, Esteban, et al.
Publicado: (2019)

Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection
por: Loke, Wai Mun, et al.
Publicado: (2013)

Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue Viruses
por: Chen, Heng-Li, et al.
Publicado: (2015)

Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection
por: Choy, Milly M., et al.
Publicado: (2015)

Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India
por: Bharaj, Preeti, et al.
Publicado: (2008)

Hypoxia enhances antibody‐dependent dengue virus infection
por: Gan, Esther Shuyi, et al.
Publicado: (2017)

Identification of All Dengue Serotypes in Nepal
por: Malla, Sarala, et al.
Publicado: (2008)

Dengue Prevention and 35 Years of Vector Control in Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2006)

A fast-growing dengue virus mutant reveals a dual role of STING in response to infection
por: Ng, Wy Ching, et al.
Publicado: (2022)

Current Status of Dengue Therapeutics Research and Development
por: Low, Jenny G. H., et al.
Publicado: (2017)

A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2017)

Evaluation of the NS1 Rapid Test and the WHO Dengue Classification Schemes for Use as Bedside Diagnosis of Acute Dengue Fever in Adults
por: Chaterji, Shera, et al.
Publicado: (2011)

Revisiting dengue virus-mosquito interactions: molecular insights into viral fitness
por: Siriphanitchakorn, Tanamas, et al.
Publicado: (2021)

Ophthalmic manifestations in seropositive dengue fever patients during epidemics caused by predominantly different dengue serotypes
por: Wagle, Ajeet M., et al.
Publicado: (2022)

Efficient Detection of Proteins Retro-Translocated from the ER to the Cytosol by In Vivo Biotinylation
por: Petris, Gianluca, et al.
Publicado: (2011)

New Tags for Recombinant Protein Detection and O-Glycosylation Reporters
por: Petris, Gianluca, et al.
Publicado: (2014)

Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Production of Infectious Dengue Virus in Aedes aegypti Is Dependent on the Ubiquitin Proteasome Pathway
por: Choy, Milly M., et al.
Publicado: (2015)

When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?
por: Guy, Bruno, et al.
Publicado: (2020)

Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection
por: Chan, Candice Y. Y., et al.
Publicado: (2019)

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes
por: Sood, Ruchi, et al.
Publicado: (2015)

Detection of all four dengue serotypes in Aedes aegypti female mosquitoes collected in a rural area in Colombia
por: Pérez-Castro, Rosalía, et al.
Publicado: (2016)

Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2018)

Dengue virus activates cGAS through the release of mitochondrial DNA
por: Sun, Bo, et al.
Publicado: (2017)

First Experimental In Vivo Model of Enhanced Dengue Disease Severity through Maternally Acquired Heterotypic Dengue Antibodies
por: Ng, Jowin Kai Wei, et al.
Publicado: (2014)

Circulation of Dengue Virus Serotype 1 Genotype V and Dengue Virus Serotype 2 Genotype III in Tocantins State, Northern Brazil, 2021–2022
por: de Souza, Ueric José Borges, et al.
Publicado: (2023)

A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
por: Raut, Rajendra, et al.
Publicado: (2015)

Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection
por: Cui, Liang, et al.
Publicado: (2018)

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
por: Lau, Yuk-Fai, et al.
Publicado: (2009)

Positive epistasis between viral polymerase and the 3′ untranslated region of its genome reveals the epidemiologic fitness of dengue virus
por: Syenina, Ayesa, et al.
Publicado: (2020)

Preventing Dengue Epidemics during the COVID-19 Pandemic
por: Wilder-Smith, Annelies, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uffssjkd2b1935goojnuan20s3